EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment

Yating Du iD, Tingzhu Cheng, Chenxuan Liu, Tingting Zhu, Chuan Guo, Shen Li, Xiangrong Rao iD, Jinpu Li iD

Diagnostics · 13.01.2023 · 13 (2) · 303

DOI: 10.3390/diagnostics13020303 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 13.01.2023. Verfasst von Yating Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science & Technology Commission, National Nature Science Foundation of China, Beijing Municipal Science & Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide, with varied clinical and histopathological features between individuals, particularly across races. As an autoimmune disease, IgAN arises from consequences of increased circulating levels of galactose-deficient IgA1 and mesangial deposition of IgA-containing immune complexes, which are recognized as key events in the widely accepted “multi-hit” pathogenesis of IgAN. The emerging evidence further provides insights into the role of genes, environment, mucosal immunity and complement system. These developments are paralleled by the increasing availability of diagnostic tools, potential biomarkers and therapeutic agents. In this review, we summarize current evidence and outline novel findings in the prognosis, clinical trials and translational research from the updated perspectives of IgAN pathogenesis.

Schlagwörter

Stichwörter der Autor:innen

Gd-IgA1clinical trialscomplement dysregulationimmunoglobulin A nephropathymicrobiotamucosa-associated lymphoid tissuemucosal immunityprognosistranslational researches

Autor:innen und Institutionen

  • Department of Nephrology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.

ORCID-Profile: Yating Du, Xiangrong Rao, Jinpu Li

Förderung

  • Beijing Municipal Science & Technology Commission
  • National Nature Science Foundation of China
  • Beijing Municipal Science & Technology Commission

Zitieren

APA

Du, Y., Cheng, T., Liu, C., Zhu, T., Guo, C., Li, S., Rao, X., & Li, J. (2023). IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment. Diagnostics, 13(2), 303. https://doi.org/10.3390/diagnostics13020303

Vancouver

Du Y, Cheng T, Liu C, Zhu T, Guo C, Li S, et al. IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment. Diagnostics. 2023;13(2):303. doi:10.3390/diagnostics13020303

BibTeX
@article{Du2023,
  author = {Du, Yating and Cheng, Tingzhu and Liu, Chenxuan and Zhu, Tingting and Guo, Chuan and Li, Shen and Rao, Xiangrong and Li, Jinpu},
  title = {IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {303},
  doi = {10.3390/diagnostics13020303}
}
Kostenlos starten →